Brown Advisory Securities, LLC Alaunos Therapeutics, Inc. Transaction History

Brown Advisory Securities, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 13, 2019	SELL	$1.61 - $3.62 $16,100 - $36,200	-10,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$2.26 - $3.27 $22,599 - $32,700	10,000 New	10,000 $32,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $601M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Brown Advisory Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Securities, LLC with notifications on news.